By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Quest Diagnostics Inc. 

One Malcolm Avenue

Teterboro  New Jersey  07608  U.S.A.
Phone: 201-393-5000 Fax: 201-462-4169



Celera Diagnostics  Collaboration agreement to establish the clinical utility of tests based on novel diagnostic markers for cardiovascular disease and diabetes.

Company News
Quest Diagnostics (DGX) Launches Three Genetic Test Panels For Predicting Hereditary Cancer Risk 5/26/2016 10:36:40 AM
Quest Diagnostics (DGX) Announces Proposed Senior Notes Offering 5/23/2016 7:20:13 AM
Quest Diagnostics (DGX) Completes Effort To Refocus On Diagnostic Information Services; Updates 2016 Revenue Outlook 5/18/2016 8:00:12 AM
Quest Diagnostics (DGX) Declares Quarterly Cash Dividend 5/18/2016 7:31:49 AM
DiaSorin S.p.A. Completes Acquisition Of The Focus Diagnostics' Molecular And Immunoassay Product Business From Quest Diagnostics (DGX) 5/16/2016 6:58:06 AM
Zika Test From Quest Diagnostics (DGX) Authorized By The FDA For Emergency Use 4/29/2016 6:16:25 AM
Quest Diagnostics (DGX) Reports First Quarter 2016 Financial Results 4/21/2016 6:40:07 AM
Biocept, Inc. (BIOC) Continues International Expansion Through Agreement With Quest Diagnostics (DGX) Mexico 4/18/2016 7:34:34 AM
Quest Diagnostics (DGX) Release: New Diagnostic Pathways Could Improve Dementia Diagnosis, According To Consensus Statements To Be Presented At The American Academy of Neurology Annual Meeting 4/15/2016 11:25:49 AM
Quest Diagnostics (DGX) New Hepatitis C Virus Test Capabilities For Recently FDA-Approved Antiviral Therapies 4/15/2016 6:53:37 AM